| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 1932267-11-2 | tert-butyl (1R,5R)-9-azabicyclo[3.3.1]nona-2,6-diene-9-carboxylate
| |
C13H19NO2 | 221.3 |
| 849022-29-3 | tert-Butyl (1-methylcyclopropyl)sulfonylcarbamate
| |
C9H17NO4S | 235.30 |
| 1420900-85-1 | tert-Butyl (1-(1,1-dioxidobenzo[d]isothiazol-3-yl)piperidin-4-yl)(Methyl)carbaMate
| |
C18H25N3O4S | 379.47 |
| 1420954-82-0 | tert-Butyl (1-(1,1-dioxidobenzo[d]isothiazol-3-yl)piperidin-3-yl)(Methyl)carbaMate
| |
C18H25N3O4S | 379.47 |
| 883008-47-7 | tert-butyl ((4-Methyl-5-(Methylthio)-4H-1,2,4-triazol-3-yl)Methyl)carbaMate
| |
C10H18N4O2S | 258.34 |
| 352275-00-4 | tert-butyl ((4-(dimethyl-l4-azanylidene)pyridin-1(4H)-yl)sulfonyl)carbamate
| |
C12H19N3O4S | 301.36 |
| 1420820-73-0 | tert-Butyl ((1-(1,1-dioxidobenzo[d]isothiazol-3-yl)piperidin-4-yl)Methyl)carbaMate
| |
C18H25N3O4S | 379.47 |
| 1036734-93-6 | Teprotumumab单抗
Teprotumumab | |
| |
| 2459946-38-2 | Teoc-L-Ile-Gly-OH
| |
C14H28N2O5Si | 332.47 |
| 2687970-96-1 | TDI-011536
| |
C19H16N4O2S | 364.4 |
| 600116-15-2 | tBuPO(NHiPr)2
| |
C10H25N2OP | 220.2921 |
| 252378-69-1 | T-Boc-aminooxy-peg2-amine
| |
C11H24N2O5 | 264.32 |
| 2805997-46-8 | Survodutide激动剂多肽
Survodutide | |
| |
| 1193111-39-5 | sulfo-SPDB
| |
C13H14N2O7S3 | 406.45 |
| 148470-19-3 | Substance P x三氟醋酸盐
Substance P xTFA | |
C65H99F3N18O15S | 1461.6534 |
| 203797-64-2 | spiro[indene-2,3'-piperidin]-1(3H)-one
| |
C13H15NO | 201.26 |
| 64775-96-8 | Spiro<3.3>heptandicarbonsaeure-2,2-diethylester
Spiroheptandicarbonsaeure-2,2-diethylester | |
C13H20O4 | 240.3 |
| 6957-22-8 | sonicotinaldehyde (4-pyridylmethylene)hydrazone
isonicotinaldehyde (4-pyridylmethylene)hydrazone | 密度：1.12g/ml
沸点：362.7℃ at 760 mmHg
|
C12H10N4 | 210.2346 |
| 663598-85-4 | SNPB
| |
C13H13N3O6S2 | 371.39 |
| 2095244-54-3 | SNIPER(BRD)-1SNIPER(BRD)-1
(S)-N-((S)-2-((S)-2-(4-(3-((1-((S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-2-oxo-6,9,12-trioxa-3-azatetradecan-14-yl)oxy)benzoyl)thiazol-2-yl)pyrrolidin-1-yl)-1-cyclohexyl-2-oxoethyl)-2-(methylamino)pro | |
C53H66ClN9O8S2 | 1056.73 |
| 2458219-65-1 | SHP2-D26
(2S,4R)-1-((S)-2-(9-(4-(4-((3-((3-Amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)-4-oxobutanoyl)piperazin-1-yl)nonanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carbox | |
C56H79ClN12O6S2 | 1115.89 |
| 2828433-56-1 | Ser-Leu-Pro-Ser-Ala-Glu-Asp-Gln-Ala-Ser-Pro-Ser-Gly-Val-Val-DOTA
| |
C76H124N20O32 | 1829.91 |
| 2097002-61-2 | Selitrectinib游离态
Selitrectinib | |
C20H21FN6O | 380.42 |
| 914454-02-7 | Secretinx醋酸盐
Secretin xAcetate | |
C132H224N44O42 | 3099.46 |
| 2044953-70-8 | Seclidemstat (mesylate)
| |
| |
| 1282606-48-7 | SCD1 inhibitor-3
| |
C19H16FN7O2 | 393.37 |
| 2259318-46-0 | SC-VC-PAB-MMAE
| |
C68H105N11O17 | 1348.62 |
| 2828433-26-5 | Sar-Arg-Val-Tyr-Ile-His-Pro-Ala TFA salt
| |
C45H68F3N13O12 | 1040.1 |
| 1796566-95-4 | Sacituzumab单抗
Sacituzumab | |
| |
| 2252262-24-9 | Sabatolimab抗体
Sabatolimab | |
| |
| 2943-26-2 | S-苄基 O-乙基 二硫代碳酸酯
S-Benzyl O-ethyl carbonodithioate | |
C10H12OS2 | 212.33 |
| 1116339-84-4 | S-甲基-S-4-吡啶基磺酰亚胺
S-Methyl-S-(4-pyridinyl)sulfoximine | |
C6H8N2OS | 156.21 |
| 766451-92-7 | S-丙基-L-半胱氨酸甲酯
Methyl S-propyl-L-cysteinate | |
C7H15NO2S | 177.26 |
| 1417789-17-3 | S-FMOC-2-氨基-5-三苯甲硫基-戊酸
(S)-Fmoc-2-amino-5-(tritylthio)-pentanoic acid | |
| |
| 1461735-85-2 | S-3,3'-二溴-1,1'-联萘-2,2'-磺酰亚胺
S-3,3'-Dibromo-1,1'-Binaphthalene-2,2'-sulfonimide | |
C20H11Br2NO4S2 | 553.24 |
| 94088-75-2 | S-2-苯并噻唑基-2-氨基-alpha-(甲氧亚氨基)-4-噻唑硫代乙酸酯
S-Benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate | |
C13H10N4O2S3 | 350.4391 |
| 91571-79-8 | S-(Chloromethyl) carbamothioate
| |
C2H4ClNOS | 125.58 |
| 193884-51-4 | S-(4-氯苯基) 10-甲基-9,10-二氢吖啶-9-硫代羧酸酯
S-(4-Chlorophenyl) 10-methyl-9,10-dihydroacridine-9-carbothioate | |
C21H16ClNOS | 365.88 |
| 2484920-02-5 | S-(4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苄基) 硫代乙酸酯
S-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl) ethanethioate | |
C15H21BO3S | 292.2 |
| 1107606-68-7 | S-(4,4,5,5,5-五氟戊基)异硫脲甲磺酸盐
S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate | |
C7H13F5N2O3S2 | 332.31 |
| 33049-93-3 | S-(3-甲基丁-2-烯-1-基) 硫代乙酸酯
S-(3-Methylbut-2-en-1-yl) ethanethioate | |
C7H12OS | 144.23 |
| 92065-70-8 | S-(3-(二甲基氨基)-3-氧代丙基)硫代乙酸酯
S-(3-(Dimethylamino)-3-oxopropyl) ethanethioate | |
C7H13NO2S | 175.25 |
| 2127875-65-2 | S-(1-羟基-2-甲基丙-2-基)甲硫代磺酸盐
S-(1-Hydroxy-2-methylpropan-2-yl)methanesulfonothioate | |
C5H12O3S2 | 184.28 |
| 78872-75-0 | S-(1-乙氧基乙基)乙烷硫代酸酯
S-(1-Ethoxyethyl) ethanethioate | |
C6H12O2S | 148.2233 |
| 72731-86-3 | S-(1,3-二氧代异吲哚啉-2-基) O-乙基 二硫代碳酸酯
S-(1,3-Dioxoisoindolin-2-yl) O-ethyl carbonodithioate | |
C11H9NO3S2 | 267.32 |
| 478646-26-3 | S)-2-N-CBZ-AMINO-PENTANE-1,5-DIOL
| 密度：1.192±0.06 g/cm3(Predicted)
熔点：103-105℃
沸点：485.2±45.0℃(Predicted)
|
C13H19NO4 | 253.29 |
| 1222097-72-4 | S 38093 盐酸盐
S 38093 Hydrochloride | |
C17H25ClN2O2 | 324.85 |
| 218600-82-9 | Ru(bpy)2([2,2'-联吡啶]-4-羧酸)][PF6]2
[Ru(bpy)2([2,2'-bipyridine]-4-carboxylic acid)][PF6]2 | |
C31H24F12N6O2P2Ru | 903.56 |
| 909395-70-6 | Romosozumab单抗
Romosozumab | |
| |
| 2922732-54-3 | RMC-9805
| |
C63H88F3N11O7 | 1168.44 |
